A comparative proteomic analysis of human and rat embryonic cerebrospinal fluid

Journal of Proteome Research

Volumn 6, Issue 9, 2007, Pages 3537-3548

  Zappaterra, Mauro D ^a,b   Lisgo, Steven N ^c   Lindsay, Susan ^c   Gygi, Steven P ^d   Walsh, Christopher A ^a,b   Ballif, Bryan A ^e  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF VERMONT   (United States)

Author keywords

Brain development; Cerebrospinal fluid; Embryonic CSF (e CSF); Human CSF; Mass spectrometry; Proteomics; Rat CSF

Indexed keywords

CARRIER PROTEIN; CELL PROTEIN; PROTEINASE INHIBITOR; SCLEROPROTEIN;

ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; CEREBROSPINAL FLUID; CONTROLLED STUDY; EMBRYO; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; RAT;

ANIMALS; BRAIN; CEREBROSPINAL FLUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EMBRYO; EXTRACELLULAR MATRIX; HUMANS; MASS SPECTROMETRY; MICE; MICROCIRCULATION; PROTEASE INHIBITORS; PROTEINS; PROTEOME; PROTEOMICS; RATS;

RATTUS; VERTEBRATA;

EID: 34948862827     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr070247w     Document Type: Article

References (46)

1. Marzesco, A. M., et al. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J. Cell Sci. 2005, 118 (Pt. 13), 2849-58.
2. Sadler, T. W. Langman's Medical Embryology, 8th ed.;Lippincott Williams & Wilkins: Baltimore, MD, 2000.
3. Saunders, N. R.; Knott, G. W.; Dziegielewska, K. M. Barriers in the immature brain. Cell. Mol. Neurobiol. 2000, 20 (1), 29-40.
4. Foster, G. Chemical Neuroanatomy of the Prenatal Rat Brain: A Developmental Atlas; Oxford University Press: Oxford, 1998.
5. Dziegielewska, K. M., et al. Development of the choroid plexus. Microsc. Res. Tech. 2001, 52 (1), 5-20.
6. O'Rahilly, R.; Muller, F. The Embryonic Human Brain: An Atlas of Developmental Stages;Wiley-Liss: New York, 1994.
7. Chodobski, A.; Szmydynger-Chodobska, J. Choroid plexus: target for polypeptides and site of their synthesis. Microsc. Res. Tech. 2001, 52 (1), 65-82.
8. Emerich, D. F., et al. The choroid plexus in the rise, fall and repair of the brain. BioEssays 2005, 27 (3), 262-74.
9. Miyan, J. A.; Nabiyouni, M.; Zendah, M. Development of the brain: a vital role for cerebrospinal fluid. Can. J. Physiol. Pharmacol. 2003, 81 (4), 317-28.
10. Kasaian, M. T.; Neet, K. E. Nerve growth factor in human amniotic and cerebrospinal fluid. Biofactors 1989, 2 (2), 99-104.
11. Massaro, A. R., et al. Nerve growth factor (NGF) in cerebrospinal fluid (CSF) from patients with various neurological disorders, Ital. J. Neurol. Sci. 1994, 15 (2), 105-8.
12. Patterson, S. L.; Grady, M. S.; Bothwell, M. Nerve growth factor and a fibroblast growth factor-like neurotrophic activity in cerebrospinal fluid of brain injured human patients. Brain Res. 1993, 605 (1), 43-9.
13. Van Setten, G. B., et al. Levels of transforming growth factor alpha (TGF-alpha) in human cerebrospinal fluid. Int. J. Dev. Neurosci. 1999, 17 (2), 131-4.
14. Sawamoto, K., et al. New neurons follow the flow of cerebrospinal fluid in the adult brain. Science 2006, 311 (5761), 629-32.
15. Gato, A., et al. Embryonic cerebrospinal fluid regulates neuroepithelial survival, proliferation, and neurogenesis in chick embryos. Anat. Rec. A Discov. Mol. Cell Evol. Biol. 2005, 284 (1), 475-84.
16. Martin, C., et al. FGF2 plays a key role in embryonic cerebrospinal fluid trophic properties over chick embryo neuroepithelial stem cells. Dev. Biol. 2006, 297 (2), 402-16.
17. Mashayekhi, F., et al. Deficient cortical development in the hydrocephalic Texas (H-Tx) rat: a role for CSF. Brain 2002, 125 (Pt. 8), 1859-74.
18. Miyan, J. A., et al. Cerebrospinal fluid supports viability and proliferation of cortical cells in vitro, mirroring in vivo development. Cerebrospinal Fluid Res. 2006, 3, 2.
19. Owen-Lynch, P. J., et al. Defective cell cycle control underlies abnormal cortical development in the hydrocephalic Texas rat. Brain 2003, 126 (Pt. 3), 623-31.
20. Parada, C., et al. Proteome analysis of chick embryonic cerebrospinal fluid. Proteomics 2006, 6 (1), 312-20.
21. Parada, C.; Gato, A.; and Bueno, D. Mammalian embryonic cerebrospinal fluid proteome has greater apolipoprotein and enzyme pattern complexity than the avian proteome. J. Proteome Res. 2005, 4 (6), 2420-8.
22. Elias, J. E., et al. Comparative evaluation of mass spectrometry platforms used in large-scale proteomics investigations. Nat. Methods 2005, 2 (9), 667-75.
23. Ballif, B. A., et al. Phosphoproteomic analysis of the developing mouse brain. Mol. Cell. Proteomics 2004, 3 (11), 1093-101.
24. Thomas, P. D., et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 2003, 13 (9), 2129-41.
25. Molnar, Z., et al. Comparative aspects of cerebral cortical development. Eur. J. Neurosci. 2006, 23 (4), 921-34.
26. Valverde, F.; De Carlos, J. A.; Lopez-Mascaraque, L. Time of origin and early fate of preplate cells in the cerebral cortex of the rat. Cereb. Cortex 1995, 5 (6), 483-93.
27. Clancy, B.; Darlington, R. B.; and Finlay, B. L. Translating developmental time across mammalian species. Neuroscience 2001, 105 (1), 7-17.
28. Palmert, M. R., et al. The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid. Proc. Natl. Acad. Sci. U.S.A. 1989, 86 (16), 6338-42.
29. Caille, I., et al. Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone. Development 2004, 131 (9), 2173-81.
30. Hayashi, Y., et al. Alzheimer amyloid protein precursor enhances proliferation of neural stem cells from fetal rat brain. Biochem. Biophys. Res. Commun. 1994, 205 (1), 936-43.
31. Ohsawa, I., et al. Amino-terminal region of secreted form of amyloid precursor protein stimulates proliferation of neural stem cells. Eur. J. Neurosci. 1999, 11 (6), 1907-13.
32. Gotz, M.; et al. Tenascin-C synthesis and influence on axonal growth during rat cortical development. Eur. J. Neurosci. 1997, 9(3), 496-506.
33. Davidsson, P., et al. Studies of the pathophysiological mechanisms in frontotemporal dementia by proteome analysis of CSF proteins. Brain Res. Mol. Brain. Res. 2002, 109 (1-2), 128-33.
34. Houenou, L. J., et al. Pigment epithelium-derived factor promotes the survival and differentiation of developing spinal motor neurons. J. Comp. Neurol. 1999, 412 (3), 506-14.
35. Ramirez-Castillejo, C., et al. Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nat. Neurosci. 2006, 9 (3), 331-9.
36. Hillenbrand, R., et al. The close homologue of the neural adhesion molecule L1 (CHL1): patterns of expression and promotion of neurite outgrowth by heterophils interactions. Eur. J. Neurosci. 1999, 11 (3), 813-26.
37. Montag-Sallaz, M.; Schachner, M.; Montag, D. Misguided axonal projections, neural cell adhesion molecule 180 mRNA upregulation, and altered behavior in mice deficient for the close homolog of L1. Mol. Cell Biol. 2002, 22 (22), 7967-81.
38. Nishimune, H., et al. Neural adhesion molecules L1 and CHL1 are survival factors for motoneurons. J. Neurosci. Res. 2005, 80 (5), 593-9.
39. Causin, C., et al. Mannose 6-phosphate/insulin-like growth factor II-binding proteins in human serum and urine. Their relation to the mannose 6-phosphate/insulin-like growth factor II receptor. Biochem. J. 1988, 252 (3), 795-9.
40. Kiess, W., et al. Type II insulin-like growth factor receptor is present in rat serum. Proc. Natl. Acad. Sci. U.S.A. 1987, 84 (21), 7720-4.
41. MacDonald, R. G., et al. Serum form of the rat insulin-like growth factor II/mannose 6-phosphate receptor is truncated in the carboxyl-terminal domain. J. Biol. Chem. 1989, 264 (6), 3256-61.
42. Xu, Y.; Papageorgiou, A.; Polychronakos, C. Developmental regulation of the soluble form of insulin-like growth factor-II/ mannose 6-phosphate receptor in human serum and amniotic fluid. J. Clin. Endocrinol. Metab. 1998, 83 (2), 437-42.
43. Zaina, S.; Squire, S. The soluble type 2 insulin-like growth factor (IGF-II) receptor reduces organ size by IGF-II-mediated and IGF-II-independent mechanisms. J. Biol. Chem. 1998, 273 (44), 28610-6.
44. Agnew, W. F., et al. Protein synthesis and transport by the rat choroid plexus and ependyma: an autoradiographic study. Cell Tissue Res. 1980, 208 (2), 261-81.
45. Gudeman, D. M., et al. Release from live choroid plexus of apical fragments and electrophoretic characterization of their synthetic products. J. Neurosci. Res. 1989, 24 (2), 184-91.
46. Joester, A.; Faissner, A. The structure and function of tenascins in the nervous system. Matrix Biol. 2001, 20(1), 13-22.